Development

INSIGHTS ON DRUG DEVELOPMENT

How A Privately Owned CDMO Is Transforming Client Expectations
Finding a partner with flexible services and a strong emphasis on building long-term client relationships can help ensure success for your pharmaceutical product.
New Approaches To Tailored Release Profiles
Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.
Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success
By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.
Navigating The Analytical Complexity Of Oligonucleotide Therapeutics
From identity and purity testing using chromatography and electrophoresis to PCR and microbial studies, explore advanced analytical solutions tailored for siRNA, miRNA, pDNA, and mRNA products.

Customer Spotlight: Queen Mary University Of London's Centre For Predictive In Vitro Models
5/10/2024

Discover the future of in vitro modeling at the Queen Mary+Emulate Organs-on-Chips Centre and unlock new possibilities in the field of predictive medicine.
Using SEC For Reliable Biotherapeutic Peptide Analysis
7/31/2025

Discover a breakthrough in analytical performance that delivers unmatched precision, faster results, and reduced waste. This innovation sets a new standard for sustainable, high-resolution analysis.
From First-In-Human To Proof-Of-Concept — Quicker, Smarter, Streamlined
10/14/2025

Explore examples of smarter SAD/MAD trial designs including multi-part and hybrid protocols, regulatory foresight, recruitment considerations, and operational strategies that keep programs moving.
Accelerate Your pDNA And mRNA Process Development
11/13/2025

Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems
4/4/2025

For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.

Multi-Mode Microplate Reader

Unlock precision and flexibility in your lab with a microplate reader that features five detection modes, hybrid optics, and advanced environmental controls for complex assay workflows.
Single-Use Automated Virus Filtration System

Learn about a single-use automated filtration system designed to deliver robust process control during this critical downstream step.
SCIEX M5 MicroLC System

See More with Microflow LC-MS

The M5 MicroLC system is the perfect balance of sensitivity and robustness—more sensitive than traditional analytical flow LC, and more flexible and more robust than nanoflow LC — giving you the potential to optimize your critical workflows, today and into the future.
MaxPeak Premier Columns For Intact And Subunit Protein Analysis

MaxPeak™ Premier Columns utilize MaxPeak High Performance Surfaces that are designed to increase analyte recovery, sensitivity, and reproducibility by minimizing analyte/surface interactions that can lead to sample losses.
Simplify Your Linker-Payload Synthesis

By streamlining the synthesis pathways, see how these products can effectively diminish the requisite number of developmental and manufacturing stages essential for generating payloads.